Clinical Trials Logo

Pain, Intractable clinical trials

View clinical trials related to Pain, Intractable.

Filter by:

NCT ID: NCT06442410 Completed - Pain, Chronic Clinical Trials

Comparison of DTM™ SCS Therapy Combined With Conventional Medical Management (CMM) to CMM Alone in the Treatment of Intractable Back Pain Subjects Without Previous History of Lumbar Spine Surgery

Start date: July 24, 2020
Phase: N/A
Study type: Interventional

The purpose of this investigational study is to document the safety, clinical effectiveness and health economic analytics of DTM™ SCS programming delivered through the Intellis™ neurostimulator in subjects with chronic, intractable pain of the trunk with or without lower limb pain, including unilateral or bilateral pain without prior history of spine surgery and refractory to conservative treatment and are not candidates for lumbar spinal surgery.

NCT ID: NCT06030284 Withdrawn - Clinical trials for Chronic Intractable Pain

The True Efficacy of Burst Spinal Cord Stimulation in the Management of Intractable Low Back Pain (TRU-BURST)

Start date: April 20, 2023
Phase: N/A
Study type: Interventional

The purpose of this prospective, multi-center, randomized, triple-blind, sham-controlled study with parallel economic evaluation is to test the analgesic superiority of BurstDR-SCS compared to sham stimulation using both traditional patient-reported pain outcome measures and objective physiologic data collected from patient-worn biosensors. The endpoints associated with these objectives will be studied across a follow-up period of 6 months.

NCT ID: NCT05970081 Recruiting - Refractory Pain Clinical Trials

Effectiveness and Safety of Implantable Intrathecal Systems for Refractory Pain in Spain (INTRATHECAL-RENASED)

Start date: August 1, 2023
Phase:
Study type: Observational [Patient Registry]

Refractory pain is a prevalent condition that negatively affects patients' quality of life. Intrathecal implantable systems have been proposed as a treatment option for refractory pain. However, real-world data on the effectiveness and safety of these therapies in Spain are scarce. This study aims to obtain real-world data on the effectiveness and safety of intrathecal implantable systems for refractory pain treatment in Spain.

NCT ID: NCT05775510 Recruiting - Pain, Chronic Clinical Trials

Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain

SENSE SCS
Start date: March 30, 2023
Phase:
Study type: Observational

Medtronic, Inc. is sponsoring the SENSE SCS clinical study, a prospective, multi-center, post-market, non-randomized, observational study with a hybrid decentralized model of execution, utilizing a mobile application for the collection of patient reported outcomes (PROs). The purpose of the study is to evaluate workflow of a mobile application for collection of PROs and to gather data on patient experience with spinal cord stimulation therapy.

NCT ID: NCT05761392 Recruiting - Pain, Chronic Clinical Trials

APP-based Precise Management System of Chronic Intractable Pain

PreMaSy
Start date: September 26, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about a new management system in chronic and stubborn pain patients who accept therapy of spinal cord stimulation (SCS). Usually, these patients are required to take long-term follow-ups to ensure that the stimulator works well. The main questions it aims to answer are: - Is it better to improve the patient's quality of life than the current conventional follow-up? - Is it better to relieve pain in the long term than the current conventional follow-up? - Is it possible to be applied to a large population of chronic pain patients? Participants will be randomly assigned to either a control group or an interventional group. Participants in the control group will be given the standard SCS implantation surgery and asked to complete the conventional follow-up (at least 1-, 3-, and 6-month post-operative). Participants in the interventional group will be given the standard SCS implantation surgery and asked to do the following things: - Take the daily pain self-assessment questions on a mobile phone APP. - Take the monthly healthy status self-assessment questionnaires on a mobile phone APP. - Take the conventional follow-up (at least 1-, 3-, and 6-month post-operative). Researchers will compare the two groups to see if the life quality of the interventional group is improved.

NCT ID: NCT05504382 Recruiting - Clinical trials for Juvenile Rheumatoid Arthritis

Effect of Electroacupuncture on Refractory Pain in Juvenile Rheumatoid Arthritis: Randomized Controlled Trial

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

the purpose of the study is to investigate the effect of Electrical Acupuncture Versus naproxen phonophoresis on Refractory pain in Juvenile Rheumatoid arthritis

NCT ID: NCT05417737 Recruiting - Chronic Pain Clinical Trials

Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025

EPOOzo
Start date: June 15, 2022
Phase:
Study type: Observational [Patient Registry]

The main objective of this study is to analyze the impact on the health-related quality of life of patients with refractory symptoms, who have been referred to the HUGCDN Chronic Pain Unit for adjuvant palliative treatment with ozone therapy between June-2022 and December-2025

NCT ID: NCT05398003 Recruiting - Pain, Intractable Clinical Trials

Medullary Stimulation for the Treatment of Refractory Neck Pain (S2M)

S2M
Start date: November 23, 2022
Phase: N/A
Study type: Interventional

Number of centres planned : 1 (CHU Nantes) Design : Randomized, Prospective Planning of the study : - Total duration: 34 months - Recruitment period: 24 months. - Follow-up time per patients : 7-10 months Expected number of cases : 12 Treatment, procedure, combination of procedures under consideration : During the study, patients will be implanted with the WAVEWRITER ALPHA™ system with the objective of decreasing patient pain with a spinal cord stimulation mode. There will be a random draw on the order of the stimulation program: - the tonic stimulation "LF": In tonic mode, the electrical stimulation of the sensory fibers of the posterior cords of the spinal cord induces local paresthesias - burst stimulation (or "burst") - high frequency" stimulation (1000 Hz) "High frequency: HF". - combined tonic + burst stimulation - combined tonic + high frequency stimulation

NCT ID: NCT05165901 Recruiting - Pain Clinical Trials

Clinical Effect of LG Medipain for Managing Chronic Pain Disorders

Start date: January 3, 2022
Phase: N/A
Study type: Interventional

Scrambler Therapy is a type of non-invasive neuromodulation. According to the researches that studied the effects of the existing Scrambler therapy, 10 times of Scrambler Therapy showed a significant pain relief lasting for more than 1-3 months in various pain disorders such as post-herpetic neuralgia, cancer-related neuropathic pain, and mixed pain. No treatment-related side effects have been reported in Scrambler therapy conducted in previous studies. The most inconvenient thing about Scrambler Therapy is that it has to be treated more than 10 times during specific period, so frequent visits to the hospital for treatment linked to the higher burden for the patient's cost and even those are not fully covered by the government's insurance. To reduce this discomfort and expand the range of treatment in the era of Corona of untact treatment, LG Electronics devised a home self-scrambler treatment device for pain patients. The LG Medipain device has the same treatment function as the existing hospital Scrambler treatment device, but there has been no study on its efficacy and safety. Therefore, the investigators want to conduct this research and find out about the safety and equal efficiency of the LG Medipain Therapy. In this study, it is expected that pain relief and improvement of quality of life can be obtained for patients with various types of chronic pain through self-application of LG Medipain device.

NCT ID: NCT05108103 Completed - Clinical trials for Complex Regional Pain Syndromes

Determination of Longus Colli Muscle Thickness by Ultrasonography

Start date: March 1, 2021
Phase:
Study type: Observational

This study aims to assess the longus colli muscle thickness by ultrasonography in order to guide stellate ganglion blocks